Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer.
- Author:
Adil ALLAHVERDIYEV
1
;
Gamze TARI
;
Melahat BAGIROVA
;
Emrah Sefik ABAMOR
Author Information
- Publication Type:Review
- Keywords: Breast neoplasms; Immunology; Immunotherapy; Vaccines
- MeSH: Allergy and Immunology; Breast Neoplasms*; Breast*; Cancer Vaccines; Cause of Death; Dendritic Cells; Developing Countries; Drug Therapy; Female; Humans; Immunotherapy; Radiotherapy; Vaccines*
- From:Journal of Breast Cancer 2018;21(4):343-353
- CountryRepublic of Korea
- Language:English
- Abstract: Cancer is the leading cause of death worldwide. In developed as well as developing countries, breast cancer is the most common cancer found among women. Currently, treatment of breast cancer consists mainly of surgery, chemotherapy, hormone therapy, and radiotherapy. In recent years, because of increased understanding of the therapeutic potential of immunotherapy in cancer prevention, cancer vaccines have gained importance. Here, we review various immunotherapeutic breast cancer vaccines including peptide-based vaccines, whole tumor cell vaccines, gene-based vaccines, and dendritic cell vaccines. We also discuss novel nanotechnology-based approaches to improving breast cancer vaccine efficiency.
